100 related articles for article (PubMed ID: 28512893)
1. Sci-Sat AM(2): Brachy-06: A Comparison of MR/CT fusion versus CT alone for assessment of implant quality in permanent prostate brachytherapy.
Sasaki DK; Malkoske K; Bews J; Cho P; Drachenberg D; Chowdhury A
Med Phys; 2008 Jul; 35(7Part3):3417. PubMed ID: 28512893
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
[TBL] [Abstract][Full Text] [Related]
3. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
[TBL] [Abstract][Full Text] [Related]
4. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
5. [CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment].
Servois V; Chauveinc L; El Khoury C; Lantoine A; Ollivier L; Flam T; Rosenwald JC; Cosset JM; Neuenschwander S
Cancer Radiother; 2003 Feb; 7(1):9-16. PubMed ID: 12648712
[TBL] [Abstract][Full Text] [Related]
6. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
Martin GV; Pugh TJ; Mahmood U; Kudchadker RJ; Wang J; Bruno TL; Bathala T; Blanchard P; Frank SJ
Brachytherapy; 2017; 16(4):761-769. PubMed ID: 28501429
[TBL] [Abstract][Full Text] [Related]
7. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
Roberson PL; McLaughlin PW; Narayana V; Troyer S; Hixson GV; Kessler ML
Med Phys; 2005 Feb; 32(2):473-82. PubMed ID: 15789594
[TBL] [Abstract][Full Text] [Related]
8. SU-D-213CD-05: Identifying Prostate Brachytherapy Seeds at MRI: A Study in Phantom.
Fatemi-Ardekani A; Borg J
Med Phys; 2012 Jun; 39(6Part3):3618. PubMed ID: 28517405
[TBL] [Abstract][Full Text] [Related]
9. Prostate seed implant quality assessment using MR and CT image fusion.
Amdur RJ; Gladstone D; Leopold KA; Harris RD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):67-72. PubMed ID: 9989515
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
[TBL] [Abstract][Full Text] [Related]
11. CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study.
Zhang M; Chu C; Huang L; Hu B
Dis Markers; 2022; 2022():6310262. PubMed ID: 35620270
[TBL] [Abstract][Full Text] [Related]
12. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy.
Crook J; Milosevic M; Catton P; Yeung I; Haycocks T; Tran T; Catton C; McLean M; Panzarella T; Haider MA
Brachytherapy; 2002; 1(2):66-73. PubMed ID: 15062173
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
[TBL] [Abstract][Full Text] [Related]
14. Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
Katayama N; Takemoto M; Takamoto A; Ihara H; Katsui K; Ebara S; Nasu Y; Kanazawa S
J Radiat Res; 2016 Jul; 57(4):393-9. PubMed ID: 26976125
[TBL] [Abstract][Full Text] [Related]
15. A software system for interventional magnetic resonance image-guided prostate brachytherapy.
Kooy HM; Cormack RA; Mathiowitz G; Tempany C; D'Amico AV
Comput Aided Surg; 2000; 5(6):401-13. PubMed ID: 11295853
[TBL] [Abstract][Full Text] [Related]
16. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
[TBL] [Abstract][Full Text] [Related]
17. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
18. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
Med Phys; 2005 Jul; 32(7Part1):2262-2270. PubMed ID: 28493573
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
20. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
